Last Price$19.1(7.5%)
Market Cap$14.6B
1M Return
(4.3%)
vs (2.4%) S&P 500
YTD Return
624.6%
vs 23.3% S&P 500
1Y Return
327.0%
vs 14.0% S&P 500
3Y Return
566.6%
vs 34.1% S&P 500
SMMT Momentum Rating
SMMT Momentum rating
8.0
SMMT Momentum rating performance
SMMT Price Performance and Momentum
Crunching data... Almost there!
Competing with SMMT Stock Price Performance
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$14.6B | 8.0 | $19.1 (7.5%) | $31.9 | $2.4 | (7.5%) | 1.5% | (4.3%) | 7.7% | 51.8% | 327.0% | 566.6% | 1,088.2% | 87.7% | 88.2% | 64.1% | 7.2% | 59.9% | 800.4% | |
$402.0B | 4.4 | $89.4 (1.4%) | $146.5 | $77.9 | (1.4%) | (1.3%) | 8.1% | (18.2%) | (34.4%) | (29.6%) | 76.2% | 207.5% | 337.2% | 20.8% | 25.2% | 15.9% | 61.0% | 114.8% | |
$125.5B | 3.0 | $483.3 0.7% | $516.7 | $392.8 | 0.7% | 0.3% | 2.8% | 5.8% | 1.6% | 14.0% | 105.1% | 111.7% | 291.3% | 27.0% | 16.2% | 14.6% | 93.5% | 123.0% | |
$74.0B | 4.1 | $684.9 (2.0%) | $1,201.8 | $663.9 | (2.0%) | (4.0%) | 2.7% | (8.6%) | (41.4%) | (29.5%) | 12.1% | 48.4% | 66.0% | 3.9% | 8.2% | 5.2% | 57.0% | 103.2% | |
$38.1B | 9.1 | $622.6 (0.3%) | $671.2 | $356.0 | (0.3%) | (0.6%) | (5.3%) | 2.7% | 21.1% | 59.5% | 128.6% | 322.5% | 2,607.0% | 31.7% | 33.4% | 60.2% | 92.8% | 174.9% | |
$31.3B | 4.6 | $243.5 (1.3%) | $300.6 | $143.3 | (1.3%) | (2.2%) | (11.3%) | (3.3%) | (4.0%) | 62.3% | 47.5% | 118.6% | 127.8% | 13.8% | 16.9% | 8.6% | 81.0% | 169.9% | |
$27.1B | 8.2 | $111.6 (1.2%) | $126.9 | $78.4 | (1.2%) | (4.6%) | (6.9%) | (3.5%) | 26.8% | 24.9% | (20.5%) | 193.8% | 693.8% | (7.4%) | 24.1% | 51.3% | 87.9% | 142.4% | |
$15.2B | 2.3 | $33.9 0.6% | $33.9 | $24.3 | 0.6% | 0.1% | 8.0% | 28.5% | 18.2% | 15.9% | (5.7%) | (16.1%) | (16.1%) | (1.9%) | (4.3%) | (4.3%) | 100.0% | 139.4% | |
$14.8B | 7.6 | $70.3 (4.4%) | $83.4 | $51.2 | (4.4%) | (5.1%) | (4.7%) | (2.5%) | 6.0% | 17.6% | 1.2% | (9.7%) | (20.1%) | 0.4% | (2.0%) | (2.2%) | 84.3% | 137.3% | |
$14.0B | 7.5 | $310.0 (3.1%) | $410.0 | $228.3 | (3.1%) | (13.5%) | (12.6%) | (15.9%) | (12.0%) | 35.5% | 77.2% | 209.4% | 96.5% | 21.0% | 25.3% | 7.0% | 75.6% | 135.8% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
FAQ
1. What is Summit Therapeutics Inc. (SMMT) 1-month return?
Summit Therapeutics Inc. (SMMT) 1-month return is (4.3%), compared to the (2.4%) return of the S&P 500.
2. What is Summit Therapeutics Inc. (SMMT) year-to-date (YTD) return?
Summit Therapeutics Inc. (SMMT) YTD return is 624.6%, compared to the 23.3% return of the S&P 500.
3. What is Summit Therapeutics Inc. (SMMT) 1-year return?
Summit Therapeutics Inc. (SMMT) 1-year return is 327.0%, compared to the 14.0% return of the S&P 500.
4. What is Summit Therapeutics Inc. (SMMT) 3-year return?
Summit Therapeutics Inc. (SMMT) 3-year return is 566.6%, compared to the 34.1% return of the S&P 500.